NO SCIENCE AT ALL: FDA grants EUA to untested bivalent COVID-19 vaccine boosters

By royluarca // 2022-09-15

Mastodon

Parler

Gab

Copy

If it works with mice, it will work with people as well. That's the insane connotation of what the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have done with their hasty grant of emergency use application (EUA) status to Pfizer's and Moderna's new boosters against the Wuhan coronavirus (COVID-19). Even without a single test on their efficacy on humans, the federal government has placed millions of orders in advance for these bivalent vaccine boosters. If the FDA and the CDC wanted to, they could have at least waited for more time and required manufacturers to conduct human trials first. After all, there's no longer a public health emergency. Of course, the FDA and the CDC would insist they made the right decision. They are in cahoots with Big Pharma as to how the COVID-19 scare would be revived. They want more people to take the additional jabs despite the fact that they have dropped the distancing and masking mandates they imposed at the height of the pandemic. More than the health concerns, however, the move by the FDA and the CDC would further enrich Big Pharma and, probably, corrupt health officials. Pfizer disclosed it is set to earn a whopping $54 billion, mainly from COVID-19 vaccine sales, and it expects another spike in sales with the rollouts of new vaccines. Although the majority of Americans have taken their first two shots, recent studies have found that they are no longer keen on getting jabbed again. Especially, if what they would be given is untested and untried. (Related: Pfizer's COVID-19 vaccine had a shocking DEATH rate of 3.7% during early trial – but the FDA approved it anyway.)

COVID-19 vaccines not reducing transmission rates

Recent studies have found that vaccines are not reducing the virus's transmission rates, nor are they boosting the immune system. Aware of the growing reluctance, the CDC and the FDA acted swiftly. On August 21, they issued the EUAs for both Pfizer and Moderna, which have decided to co-exist rather than tangle in the highly lucrative market. Pfizer's vaccine is intended for the omicron subvariants BA4 and BA5 while Moderna's is aimed at the main strain and the subvariant BA1. "The Moderna COVID-19 vaccine, bivalent, is authorized for use as a single booster dose in individuals 18 years of age and older. The Pfizer-BioNTech COVID-19 vaccine, bivalent, is authorized for use as a single booster dose in individuals 12 years of age and older," the FDA stated. Since these boosters are still under EUA only, their manufacturers have no liability for injuries and other adverse effects that may happen after the injection. No wonder, the cartel-like movement of Big Pharma and the health agencies has drawn criticisms and resentments. Some researchers and health experts are convinced the new COVID vaccines are designed for "immune imprinting," a phenomenon where initial exposure to a virus strain may prevent the body from producing enough neutralizing antibodies against a new viral strain. Also, there is no evidence that the new vaccines are safe, according to Dr. Meryl Nass, who warned in his article on Expose: "Watch out. There is nothing good about them, and we should be worried about why they are being used." "There is limited evidence that they may be more harmful than earlier COVID-19 vaccines – but in the absence of human testing, there is no way to truly predict their safety," Nass said. "Safety data is being concealed by federal health agencies." Big Pharma and health agencies already tried to hide the results of the vaccines' adverse effects last year. Now, they've pulled off a fast one again. Visit Vaccines.news for more news related to COVID-19 vaccines. Watch the video below explaining how Pfizer and Moderna are trying to skip clinical trials for future vaccines. This video is from In Search of Truth channel on Brighteon.com.

CITIZENS NEWS

COVID-19 vaccines not reducing transmission rates

More related stories: